Sam McLenachan

Sam McLenachan is an Adjunct Senior Research Fellow at the University of Western Australia (UWA), affiliated with the UWA Medical School and the Centre for Ophthalmology and Visual Science (linked to the Lions Eye Institute). His research focuses on stem cell biology, retinal diseases, and genetic disorders, with a particular emphasis on induced pluripotent stem cells (iPSCs) and their applications in clinical settings.

Key research interests include the generation and use of iPSC lines for studying retinal dystrophies (e.g., PRPF31 mutations), nanoparticle-based gene therapy for retinal delivery, and optimizing stem cell-derived therapies for ocular conditions. He has contributed to projects addressing splice-altering mutations in inherited retinal diseases and personalized disease modeling.

Notable grants include leadership roles in NHMRC-funded initiatives and collaborations with institutions like Retina Australia. His work aligns with UN Sustainable Development Goals related to health and well-being (SDG 3).

McLenachan has published extensively in journals such as Stem Cell Research and Journal of Drug Targeting, with a focus on advancing regenerative medicine and therapeutic strategies for genetic eye disorders.